647 related articles for article (PubMed ID: 26536459)
1. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
Geraldo MV; Nakaya HI; Kimura ET
Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
[TBL] [Abstract][Full Text] [Related]
3. Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
Cahill S; Smyth P; Finn SP; Denning K; Flavin R; O'Regan EM; Li J; Potratz A; Guenther SM; Henfrey R; O'Leary JJ; Sheils O
Mol Cancer; 2006 Dec; 5():70. PubMed ID: 17156473
[TBL] [Abstract][Full Text] [Related]
4. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
[TBL] [Abstract][Full Text] [Related]
5. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
[TBL] [Abstract][Full Text] [Related]
6. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
7. Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
Cahill S; Smyth P; Denning K; Flavin R; Li J; Potratz A; Guenther SM; Henfrey R; O'Leary JJ; Sheils O
Mol Cancer; 2007 Mar; 6():21. PubMed ID: 17355635
[TBL] [Abstract][Full Text] [Related]
8. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
9. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
[TBL] [Abstract][Full Text] [Related]
10. Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling.
Aherne ST; Smyth PC; Flavin RJ; Russell SM; Denning KM; Li JH; Guenther SM; O'Leary JJ; Sheils OM
Mol Cancer; 2008 Dec; 7():89. PubMed ID: 19055826
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.
Huang CT; Oyang YJ; Huang HC; Juan HF
Sci Rep; 2014 Sep; 4():6495. PubMed ID: 25263162
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression in anaplastic thyroid carcinomas.
Hébrant A; Floor S; Saiselet M; Antoniou A; Desbuleux A; Snyers B; La C; de Saint Aubain N; Leteurtre E; Andry G; Maenhaut C
PLoS One; 2014; 9(8):e103871. PubMed ID: 25153510
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma.
Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X
Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809
[TBL] [Abstract][Full Text] [Related]
17. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
Najafi A; Tavallaei M; Hosseini SM
Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
[TBL] [Abstract][Full Text] [Related]
18. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
19. MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.
Floor SL; Hebrant A; Pita JM; Saiselet M; Trésallet C; Libert F; Andry G; Dumont JE; van Staveren WC; Maenhaut C
PLoS One; 2014; 9(11):e111581. PubMed ID: 25375362
[TBL] [Abstract][Full Text] [Related]
20. Identifying cancer-related microRNAs based on gene expression data.
Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]